Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 878Pancreatic Neoplasms 572Carcinoma, Hepatocellular 542Stomach Neoplasms 512Esophageal Neoplasms 312Rectal Neoplasms 280Colonic Neoplasms 254Breast Neoplasms 203Neoplasms 201Liver Neoplasms 187Lung Neoplasms 174Carcinoma, Non-Small-Cell Lung 174Cholangiocarcinoma 153Ovarian Neoplasms 141Neoplasm Metastasis 135Gastrointestinal Neoplasms 133Esophageal Squamous Cell Carcinoma 130Melanoma 103Prostatic Neoplasms 98Biliary Tract Neoplasms 95Endometrial Neoplasms 83Uterine Cervical Neoplasms 79Head and Neck Neoplasms 72Squamous Cell Carcinoma of Head and Neck 69Carcinoma, Renal Cell 58Sarcoma 54Adenocarcinoma Of Esophagus 54Urinary Bladder Neoplasms 53Anus Neoplasms 52Triple Negative Breast Neoplasms 48

Interventions

Taxes 1Specimen Handling 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Catheter Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pancreatic Cystic Neoplasm × Gastrointestinal × Clear all
NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡